Adma Biologics (ADMA) Cash from Investing Activities Growth (5y) (2016 - 2025)
Adma Biologics (ADMA) Cash from Investing Activities Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Adma Biologics | 2.04 Bn | 1.95 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.16% |
| Sep 30, 2025 | -37.86% |
| Jun 30, 2025 | 9.53% |
| Mar 31, 2025 | -17.89% |
| Dec 31, 2024 | -11.52% |
| Sep 30, 2024 | 11.05% |
| Jun 30, 2024 | -77.24% |
| Mar 31, 2024 | -84.51% |
| Dec 31, 2023 | -11.43% |
| Sep 30, 2023 | -26.88% |
| Jun 30, 2023 | -11.89% |
| Mar 31, 2023 | -28.77% |
| Dec 31, 2022 | -13.28% |
| Sep 30, 2022 | -42.77% |
| Jun 30, 2022 | -18.24% |
| Mar 31, 2022 | -20.62% |
| Dec 31, 2021 | -21.55% |
| Sep 30, 2021 | -68.72% |
| Jun 30, 2021 | 12.28% |
| Mar 31, 2021 | -22.01% |